Literature DB >> 26640596

Expression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese Exposure.

Christopher A Bates1, Sherleen Fu1, Daniel Ysselstein2, Jean-Christophe Rochet2, Wei Zheng1.   

Abstract

The choroid plexus maintains the homeostasis of critical molecules in the brain by regulating their transport between the blood and cerebrospinal fluid (CSF). The current study was designed to investigate the potential role of the blood-CSF barrier (BCSFB) in α-synuclein (a-Syn) transport in the brain as affected by exposure to manganese (Mn), the toxic metal implicated in Parkinsonian disorders. Immunohistochemistry was used to identify intracellular a-Syn expression at the BCSFB. Quantitative real-time PCR was used to quantify the change in a-Syn mRNA expression following Mn treatments at the BCSFB in vitro. ELISA was used to quantify a-Syn levels following in vivo and in vitro treatments of Mn, copper (Cu), and/or external a-Syn. Thioflavin-T assay was used to investigate a-Syn aggregation after incubating with Mn and/or Cu in vitro. A two-chamber Transwell system was used to study a-Syn transport by BCSFB monolayer. Data revealed the expression of endogenous a-Syn in rat choroid plexus tissue and immortalized choroidal epithelial Z310 cells. The cultured primary choroidal epithelia from rats showed the ability to take up a-Syn from extracellular medium and transport a-Syn across the cellular monolayer from the donor to receiver chamber. Exposure of cells with Mn induced intracellular a-Syn accumulation without causing any significant changes in a-Syn mRNA expression. A significant increase in a-Syn aggregation in a cell-free system was observed with the presence of Mn. Moreover, Mn exposure resulted in a significant uptake of a-Syn by primary cells. These data indicate that the BCSFB expresses a-Syn endogenously and is capable of transporting a-Syn across the BCSFB monolayer; Mn exposure apparently increases a-Syn accumulation in the BCSFB by facilitating its uptake and intracellular aggregation.

Entities:  

Keywords:  a-synuclein transport; blood-cerebrospinal fluid barrier; cerebrospinal fluid; manganese exposure

Year:  2015        PMID: 26640596      PMCID: PMC4669215          DOI: 10.5599/admet.3.1.159

Source DB:  PubMed          Journal:  ADMET DMPK        ISSN: 1848-7718


  54 in total

1.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

Review 2.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

3.  Brain uptake of trace metals, zinc and manganese, in rats.

Authors:  A Takeda; T Akiyama; J Sawashita; S Okada
Journal:  Brain Res       Date:  1994-03-21       Impact factor: 3.252

4.  Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity.

Authors:  Gang Zheng; Jingyuan Chen; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-18       Impact factor: 4.219

5.  alpha-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells.

Authors:  Yan Li; Liguang Sun; Tongjian Cai; Ying Zhang; Shijie Lv; Yu Wang; Liping Ye
Journal:  Brain Res Bull       Date:  2009-11-20       Impact factor: 4.077

6.  Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.

Authors:  Yu Lu; Michel Prudent; Bruno Fauvet; Hilal A Lashuel; Hubert H Girault
Journal:  ACS Chem Neurosci       Date:  2011-09-14       Impact factor: 4.418

7.  Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated.

Authors:  Robert A Yokel; Janelle S Crossgrove; Bonny L Bukaveckas
Journal:  Neurotoxicology       Date:  2003-01       Impact factor: 4.294

8.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

9.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

10.  α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system.

Authors:  Brit Mollenhauer; Ellen Trautmann; Birgit Otte; Juliana Ng; Annette Spreer; Peter Lange; Friederike Sixel-Döring; Mansoureh Hakimi; Jean-Paul Vonsattel; Robert Nussbaum; Claudia Trenkwalder; Michael G Schlossmacher
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

View more
  10 in total

1.  Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.

Authors:  Dharmin Rokad; Shivani Ghaisas; Dilshan S Harischandra; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Brain Res Bull       Date:  2016-12-16       Impact factor: 4.077

2.  Distribution of α-Synuclein Aggregation in the Peripheral Tissues.

Authors:  Yan-Yan Li; Tian-Tian Zhou; Yi Zhang; Nai-Hong Chen; Yu-He Yuan
Journal:  Neurochem Res       Date:  2022-03-28       Impact factor: 3.996

3.  Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.

Authors:  Patrick Oeckl; Fabian Metzger; Magdalena Nagl; Christine A F von Arnim; Steffen Halbgebauer; Petra Steinacker; Albert C Ludolph; Markus Otto
Journal:  Mol Cell Proteomics       Date:  2016-08-09       Impact factor: 5.911

4.  Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.

Authors:  Chun-Wei Chang; Shieh-Yueh Yang; Che-Chuan Yang; Chia-Wen Chang; Yih-Ru Wu
Journal:  Front Neurol       Date:  2020-01-21       Impact factor: 4.003

Review 5.  Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System.

Authors:  Daniela C Ivan; Sabrina Walthert; Kristina Berve; Jasmin Steudler; Giuseppe Locatelli
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

6.  Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.

Authors:  Jingru Ren; Chenxi Pan; Yajie Wang; Chen Xue; Huixia Lin; Jianxia Xu; Hui Wang; Wenbin Zhang; Pingyi Xu; Yong Chen; Weiguo Liu
Journal:  J Neurochem       Date:  2022-03-18       Impact factor: 5.546

7.  Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.

Authors:  Karin Tuschl; Esther Meyer; Leonardo E Valdivia; Ningning Zhao; Chris Dadswell; Alaa Abdul-Sada; Christina Y Hung; Michael A Simpson; W K Chong; Thomas S Jacques; Randy L Woltjer; Simon Eaton; Allison Gregory; Lynn Sanford; Eleanna Kara; Henry Houlden; Stephan M Cuno; Holger Prokisch; Lorella Valletta; Valeria Tiranti; Rasha Younis; Eamonn R Maher; John Spencer; Ania Straatman-Iwanowska; Paul Gissen; Laila A M Selim; Guillem Pintos-Morell; Wifredo Coroleu-Lletget; Shekeeb S Mohammad; Sangeetha Yoganathan; Russell C Dale; Maya Thomas; Jason Rihel; Olaf A Bodamer; Caroline A Enns; Susan J Hayflick; Peter T Clayton; Philippa B Mills; Manju A Kurian; Stephen W Wilson
Journal:  Nat Commun       Date:  2016-05-27       Impact factor: 14.919

Review 8.  Untangling the Manganese-α-Synuclein Web.

Authors:  Tanara Vieira Peres; Nancy L Parmalee; Ebany J Martinez-Finley; Michael Aschner
Journal:  Front Neurosci       Date:  2016-08-04       Impact factor: 4.677

Review 9.  Choroid plexus and the blood-cerebrospinal fluid barrier in disease.

Authors:  Peter Solár; Alemeh Zamani; Lucie Kubíčková; Petr Dubový; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2020-05-06

10.  Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson's Disease Patients.

Authors:  Priscilla Youssef; Woojin S Kim; Glenda M Halliday; Simon J G Lewis; Nicolas Dzamko
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.